Amgen Inc. (AMGN) Tops Q1 EPS by 5c, Reaffirms Outlook
Amgen Inc. (NASDAQ: AMGN) reported Q1 EPS of $1.34, $0.05 better than the analyst estimate of $1.29. Revenue for the quarter came in at $3.7 million versus the consensus estimate of $3.68 billion.